This inventor holds 1 USPTO granted patent. Top assignee: De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzion,. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: Petra De Vries: Innovator in Immunogenic Complexes
Introduction
Petra De Vries is a notable inventor based in Almere, Netherlands. She has made significant contributions to the field of immunology through her innovative work on immunogenic complexes. Her research focuses on enhancing vaccine efficacy, which is crucial for public health.
Latest Patents
Petra De Vries holds a patent for a "Process for preparing immunogenic complexes and pharmaceutical." This invention involves a method where an amphiphatic antigenic protein or peptide is contacted with a solution containing a detergent, a sterol, and a glycoside. The process aims to create immunogenic complexes that are more effective than traditional methods, such as micelles and liposomes. The preferred sterol used in her process is cholesterol, and the glycosides include saponins, particularly Quil A. This innovative approach has the potential to improve vaccine formulations significantly.
Career Highlights
Throughout her career, Petra has demonstrated a commitment to advancing immunological research. Her work has led to the development of more effective vaccines, which can have a lasting impact on disease prevention. She is recognized for her expertise and contributions to the scientific community.
Collaborations
Petra has collaborated with notable colleagues, including Antonius L Van Wezel, who is now deceased, and Eduard C Beuvery. These collaborations have enriched her research and contributed to the success of her innovations.
Conclusion
Petra De Vries is a pioneering inventor whose work on immunogenic complexes is paving the way for advancements in vaccine development. Her contributions are vital for enhancing public health through improved immunization strategies.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile